RNS No 1023r
CASSELL PLC
2nd November 1998


                                                    FORM 8.1/8.3

Lodged with Company Announcements Office (which will publicise and
copy to the Panel).  Use separate form for each class of
securities in which dealings have been made.

                       Date of disclosure  MONDAY, 2ND NOVEMBER 1998

DISCLOSURE UNDER RULES 8.1(a), 8.1(b)(i) AND 8.3 OF THE CITY CODE ON
TAKEOVERS AND MERGERS

Date of dealing  FRIDAY, 30TH OCTOBER 1998

Dealing in ......... CASSELL ................... (name of company)

(1)  Class of securities (e.g. ordinary shares) 20P ORDINARY SHARES

(2)     Amount bought          Amount sold         Price per unit

              -                  659,599                125P

(3)  Resultant total of the same class owned or controlled
     (and percentage of class) ........ 291,171....... (3.96%)

(4)  Party making disclosure ........ AMVESCAP PLC ................

(5)  EITHER  (a)  Name of purchaser/vendor (Note 1) ..............

     OR      (b)  If dealing for discretionary client(s), name of
                  fund management organisation

     ................... AMVESCAP PLC ............................

(6)  Reason for disclosure (Note 2)
     (a)  associate of   (i)   offeror (Note 3)         NO
                         (ii)  offeree company          YES

     Specify which category or categories of
     associate (1-8 overleaf) .....................................

     If category (8), explain ......................................
     ...............................................................
     (b)  Rule 8.3 (i.e. disclosure because of ownership or control
     of 1% or more of the class of relevant securities dealt in)YES

Signed, for and on behalf of the party named in (4) above  A. TULLY


(Also print name of signatory) ........ANGELA TULLY................

Telephone and extension number 0171-454 3652 .......................

                ----------------------------------

Note 1  Specify   owner,  not  nominee  or  vehicle   company.    If
        relevant, also identify controller of owner, e.g.  where  an
        owner normally acts on instructions of a controller.
Note 2  Disclosure  might be made for more than one reason;  if  so,
        state all reasons.
Note 3  Specify which offeror if there is more than one.
Note 4  When  an  arrangement  exists with  any  offeror,  with  the
        offeree  company or with an associate of any offeror  or  of
        the  offeree  company  in relation to  relevant  securities,
        details  of such arrangement must be disclosed, as  required
        by Note 6 on Rule 8.
Note 5  It   may   be   necessary,  particularly   when   disclosing
        derivative   transactions,  to  append  a  sheet   to   this
        disclosure  form  so  that all relevant information  can  be
        given.
Note 6  In  the  case  of an average price bargain, each  underlying
        trade should be disclosed.

For full details of disclosure requirements, see Rule 8 of the Code.
If in doubt, contact the Panel on Takeovers and Mergers, Tel. No.
0171-382 9026.

END

DCCUBGWWGBGRGUP
Cello Health (LSE:CLL)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Cello Health Charts.
Cello Health (LSE:CLL)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Cello Health Charts.